Evidence map›Paper›PMID 39596024›Full record

ArticleInternational journal of molecular sciences2024

Deciphering Folate Receptor alphaGene Expression and mRNA Signatures in Ovarian Cancer: Implications for Precision Therapies.

Maria Kfoury, Pascal Finetti, Emilie Mamessier, François Bertucci, Renaud Sabatier

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria KfouryMedical Oncology Department, Institut Paoli-Calmettes, 13009 Marseille, France.ORCID 0000-0003-2806-413X
Pascal FinettiPredictive Oncology Laboratory, Inserm UMR1068, Centre National de la Recherche Scientifique (CNRS) UMR7258, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille University U105, 13009 Marseille, France.ORCID 0000-0002-2674-3123
Emilie MamessierPredictive Oncology Laboratory, Inserm UMR1068, Centre National de la Recherche Scientifique (CNRS) UMR7258, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille University U105, 13009 Marseille, France.
François BertucciMedical Oncology Department, Institut Paoli-Calmettes, 13009 Marseille, France.ORCID 0000-0002-0157-0959
Renaud SabatierMedical Oncology Department, Institut Paoli-Calmettes, 13009 Marseille, France.ORCID 0000-0002-5821-682X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody-drug conjugates targeting folate receptor alpha (FRα) are a promising treatment for platinum-resistant ovarian cancer (OC) with high FRα expression. Challenges persist in accurately assessing FRα expression levels. Our study aimed to better elucidate FRα gene expression and identify mRNA signatures in OC. We pooled OC gene expression data from 16 public datasets, encompassing 1832 OC and 30 normal ovarian tissues. Additional data included DNA copy number and methylation data from TCGA and protein data from 363 cancer cell lines from the Broad Institute Cancer Cell Line Encyclopedia.

Indexed as

Folate Receptor 1Gene Expression Regulation, NeoplasticOvarian NeoplasmsRNA, MessengerAgedBiomarkers, TumorCell Line, TumorDNA MethylationFemaleGene Expression ProfilingHumansMiddle AgedPrecision MedicinePrognosisTranscriptomeBiomarkers, TumorFolate Receptor 1FOLR1 protein, humanRNA, Messengerfolate receptor alphagene expressionmRNAovarian carcinoma

Identifiers

PMID39596024
PMCPMC11593678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.